These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38114091)

  • 1. Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
    Howells L
    Br J Dermatol; 2024 Jul; 191(2):e4. PubMed ID: 38114091
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient prioritisation of items to develop the Patient-Reported Impact of Dermatological Diseases measure: A global Delphi study.
    Trialonis-Suthakharan N; Pattinson R; Tahmasebi Gandomkari N; Austin J; Janus C; Courtier N; Hewitt RM; Bundy C; Augustin M
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1391-1400. PubMed ID: 38400660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further refinement of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure using classical test theory and item response theory.
    Pattinson R; Trialonis-Suthakharan N; Pickles T; Austin J; FitzGerald A; Augustin M; Bundy C
    Br J Dermatol; 2024 Apr; 190(5):718-728. PubMed ID: 38064666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure.
    Pattinson R; Trialonis-Suthakharan N; Hewitt RM; Valencia López MJ; Tahmasebi Gandomkari N; Austin J; FitzGerald A; Courtier N; Augustin M; Bundy C
    Front Med (Lausanne); 2023; 10():1020523. PubMed ID: 37215711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient prioritisation of impact items to develop the patient-reported impact of dermatological diseases (PRIDD) measure: European Delphi data.
    Trialonis-Suthakharan N; Pattinson R; Tahmasebi Gandomkari N; Austin J; Janus C; Courtier N; Hewitt RM; Bundy C; Augustin M
    J Eur Acad Dermatol Venereol; 2023 Oct; 37 Suppl 7():40-50. PubMed ID: 37805995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Conceptual Framework for a Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure: A Qualitative Concept Elicitation Study.
    Pattinson R; Hewitt RM; Trialonis-Suthakharan N; Chachos E; Courtier N; Austin J; Janus C; Augustin M; Bundy C
    Acta Derm Venereol; 2022 Nov; 102():adv00823. PubMed ID: 36065743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why measure quality of life in dermatology?
    Abeni D; Sampogna F
    G Ital Dermatol Venereol; 2013 Jun; 148(3):237-41. PubMed ID: 23670059
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure.
    Pattinson R; Trialonis-Suthakharan N; Pickles T; Austin J; FitzGerald A; Augustin M; Bundy C
    Br J Dermatol; 2024 Jun; ():. PubMed ID: 38924720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of life in dermatology. From measurement to practical implementation].
    Müller K; Karrer S; Apfelbacher C; Blome C; Berneburg M; Koller M
    Hautarzt; 2015 Apr; 66(4):287-96; quiz 297-8. PubMed ID: 25822586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciding on the final set of questions and groups of questions in the Patient-Reported Impact of Dermatological Diseases (PRIDD) tool.
    Br J Dermatol; 2024 Apr; 190(5):e57. PubMed ID: 38630927
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-Reported Outcome Measures in Dermatology: A Systematic Review.
    Pattinson RL; Trialonis-Suthakharan N; Gupta S; Henry AL; Lavallée JF; Otten M; Pickles T; Courtier N; Austin J; Janus C; Augustin M; Bundy C
    Acta Derm Venereol; 2021 Sep; 101(9):adv00559. PubMed ID: 34263330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of quality of life in dermatology].
    Augustin M; Amon U; Braathen L; Bullinger M; Gieler U; Klein GF; Schultz-Amlung W
    J Dtsch Dermatol Ges; 2004 Sep; 2(9):802-6. PubMed ID: 16279226
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initiatives to increase the efficiency of dermatological patient care].
    Knol A; Damstra RJ; van den Akker TW; de Haan J
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2514-5; author reply 2515. PubMed ID: 17137102
    [No Abstract]   [Full Text] [Related]  

  • 14. The Evolution of Quality of Life Assessment and Use in Dermatology.
    Chernyshov PV
    Dermatology; 2019; 235(3):167-174. PubMed ID: 30928986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and questionnaires in dermatology.
    Buendía-Eisman A; Arias-Santiago S
    Actas Dermosifiliogr; 2016; 107(6):449-50. PubMed ID: 27265260
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the Dermatology Life Quality Index suite of patient-reported outcome measures in skin-related neglected tropical diseases.
    Junejo MH; Wolfe I; Patel J; Duus E; Oyebanji O; Walker SL
    Br J Dermatol; 2023 Sep; 189(4):490-492. PubMed ID: 37399250
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic.
    Asabor EN; Bunick CG; Cohen JM; Perkins SH
    J Am Acad Dermatol; 2021 Jan; 84(1):158-161. PubMed ID: 32946971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initiatives to increase the efficiency of dermatological patient care].
    van de Kerkhof PC
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1873-6. PubMed ID: 16970008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of disease severity in dermatology].
    Deckert S; Apfelbacher C; Schmitt J
    Hautarzt; 2015 Sep; 66(9):699-711. PubMed ID: 26281899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need and greed in dermatology: disease and outcome measures in dermatological healthcare planning.
    Dalgard F; Finlay AY
    Dermatology; 2006; 213(4):279-83. PubMed ID: 17135732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.